Efficacy and tolerability of candesartan 16 mg plus hydrochlorothiazide 12.5 mg fixed combination vs. previous monotherapy plus hydrochlorothiazide in essential hypertension

被引：0
|
作者：
Omboni, S
Mancia, G
机构：
[1] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Monza, Italy
[2] Ist Auxol Italiano, Milan, Italy
来源：
JOURNAL OF HYPERTENSION | 2004年 / 22卷
关键词：
D O I：
10.1097/00004872-200406002-00899
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S256 / S256
页数：1
相关论文
共 50 条
  • [1] Candesartan plus hydrochlorothiazide fixed combination vs previous monotherapy plus diuretic in poorly controlled essential hypertensive patients
    Mancia, G
    Omboni, S
    [J]. BLOOD PRESSURE, 2004, 13 : 11 - 17
  • [2] The combination tablet of candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg has a tolerability profile similar to that of placebo
    Belcher, G
    Lunde, H
    Elmfeldt, D
    George, M
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 : S94 - S94
  • [3] Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy
    Boenner, Gerd
    [J]. BLOOD PRESSURE, 2008, 17 : 22 - 30
  • [4] EFFICACY AND TOLERABILITY OF ENALAPRIL (20-MG) HYDROCHLOROTHIAZIDE (12.5-MG) COMBINATION THERAPY IN ESSENTIAL-HYPERTENSION
    STROCCHI, E
    BOSSINI, A
    RANIERI, G
    FILITTI, V
    [J]. CLINICAL THERAPEUTICS, 1991, 13 (06) : 737 - 746
  • [5] Comparison of the antihypertensive effects of the candesartan 8 mg-hydrochlorothiazide 12.5 mg combination (C8+H) vs the valsartan 80 mg-hydrochlorothiazide 12.5 mg combination (V80+H) in patients with essential hypertension resistant to monotherapy
    Azizi, M
    Nisse-Durgeat, S
    [J]. JOURNAL OF HYPERTENSION, 2004, 22 : S254 - S255
  • [6] Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension
    Baumgart, Peter
    Naudts, Ingomar
    Kiel, Gerhard
    [J]. PRAGMATIC AND OBSERVATIONAL RESEARCH, 2011, 2 : 5 - 12
  • [7] EFFICACY AND TOLERABILITY OF A FIXED COMBINATION OF METOPROLOL CR ZOK 100 MG AND HYDROCHLOROTHIAZIDE (HCT) 12.5 MG IN COMPARISON WITH THE FIXED COMBINATION OF METOPROLOL AND HCT
    LEIKERSFELDT, G
    RASMUSSEN, SL
    ATMER, B
    HJALMERS, S
    WAHLQVIST, I
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (02): : S78 - S81
  • [8] Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice
    Bramlage, Peter
    Zemmrich, Claudia
    Ketelhut, Reinhard
    Wolf, Wolf-Peter
    Fronk, Eva-Maria
    Schmieder, Roland E.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 475 - 483
  • [9] A comparison of the antihypertensive and metabolic effects of lisinopril 20 mg/hydrochlorothiazide 12.5 mg fixed combination with captopril 50 mg/hydrochlorothiazide 25 mg fixed combination
    Milon, H
    Baleydier, A
    [J]. THERAPIE, 1997, 52 (03): : 195 - 205
  • [10] STUDY OF THE EFFICACY AND SAFETY OF THE COMBINATION RAMIPRIL 2.5-MG PLUS HYDROCHLOROTHIAZIDE 12.5-MG IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION
    GENTHON, R
    RANGOONWALA, B
    ANDRIEUXLACLAVELINE, A
    ARNAUD, J
    BALLADE, M
    BILLOU, J
    BOSREDON, A
    BOUTGES, B
    DUBON, T
    GOIGOUX, B
    LALANNE, G
    LAURENTJOYE, F
    LION, A
    LORANS, P
    MAURAT, X
    MOULINET, P
    RICARD, L
    ROCHE, A
    SDRIGOTTI, D
    SDRIGOTTI, J
    BUGNON, P
    DELOGE, J
    GENIN, M
    JACSON, P
    LAMIZET, P
    MOURAUX, J
    STRAUSS, P
    TAQUE, R
    VINCENT, J
    BOULEN, Y
    BOYAVAL, B
    DANDOY, P
    DELESCLUSE, D
    DENIS, X
    DERMAUT, G
    DEROIDE, F
    GHIENNE, JP
    HERMEL, R
    JAILLARD, T
    MANIGLIER, G
    MEURISSE, F
    RICHARD, G
    TIBERGHIEN, P
    VANDENDRIESSCHE, P
    VANNIER, P
    AGNIEL, P
    ARMAND, C
    BOICHON, P
    BOULE, G
    CHAPPUY, D
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1994, 14 (01) : 1 - 9
12345